recent research, that troponins levels might be elevated in certain non-cardiac conditions such as pulmonary embolism, sepsis and renal insufficiency inter alias[42]. It has been noted in patients with ESRD that, without any symptoms or signs of ACS, troponin level is elevated. Such findings put clinicians in a dilemma in the realm of diagnostics and treatment.
Renal and cardiovascular diseases are intricately linked showing a moderately high level of co-occurrence. It has been noted that cardiovascular diseases accounts for approximately 50% of deaths in patients with renal diseases. Also, patients with chronic renal failure have been known to exhibit multiple silent ischemic events and several idiosyncrasies associated with the ACS. The reliability of electrocardiogrphs becomes secondary to electrolytic disturbance, conduction abnormalities and LV hypertrophy, thereby compounding the process of recognizing nature of the disease[40].
It can be said that the cardiac troponins have become a standard biomarker for assessing cardiac injury. But there are several other cardiac markers as well, But the complication arises as the characteristic levels of these …show more content…
It indicates a higher risk in terms of mortality and morbidity, irrespective of whether the patient is asymptomatic or not for an acute MI[40]. No specific guidelines are present till date for the treatment of suspected ACS with increased troponins in ERSD patients and mostly, it is dealt with in accordance with individual cases. Clinical stability and results of electrocardiograph should be monitored appropriately in such patients. It is advised that aspirin, beta-blocker, oxygen and nitro-glycerine should be given to the patients. Heart diseases should be diagnosed properly using echocardiogram and
Renal and cardiovascular diseases are intricately linked showing a moderately high level of co-occurrence. It has been noted that cardiovascular diseases accounts for approximately 50% of deaths in patients with renal diseases. Also, patients with chronic renal failure have been known to exhibit multiple silent ischemic events and several idiosyncrasies associated with the ACS. The reliability of electrocardiogrphs becomes secondary to electrolytic disturbance, conduction abnormalities and LV hypertrophy, thereby compounding the process of recognizing nature of the disease[40].
It can be said that the cardiac troponins have become a standard biomarker for assessing cardiac injury. But there are several other cardiac markers as well, But the complication arises as the characteristic levels of these …show more content…
It indicates a higher risk in terms of mortality and morbidity, irrespective of whether the patient is asymptomatic or not for an acute MI[40]. No specific guidelines are present till date for the treatment of suspected ACS with increased troponins in ERSD patients and mostly, it is dealt with in accordance with individual cases. Clinical stability and results of electrocardiograph should be monitored appropriately in such patients. It is advised that aspirin, beta-blocker, oxygen and nitro-glycerine should be given to the patients. Heart diseases should be diagnosed properly using echocardiogram and